KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AbbVie (ABBV) EPS (Basic) (2016 - 2025)

AbbVie (ABBV) has disclosed EPS (Basic) for 14 consecutive years, with $1.02 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Basic) rose 10300.0% to $1.02 in Q4 2025 year-over-year; TTM through Dec 2025 was $2.37, a 1.66% decrease, with the full-year FY2025 number at $2.37, down 1.25% from a year prior.
  • EPS (Basic) was $1.02 for Q4 2025 at AbbVie, up from $0.1 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $2.52 in Q1 2022 to a low of -$0.01 in Q4 2024.
  • A 5-year average of $1.03 and a median of $0.82 in 2024 define the central range for EPS (Basic).
  • Peak YoY movement for EPS (Basic): surged 22600.0% in 2021, then plummeted 102.17% in 2024.
  • AbbVie's EPS (Basic) stood at $2.27 in 2021, then tumbled by 38.77% to $1.39 in 2022, then crashed by 66.91% to $0.46 in 2023, then tumbled by 102.17% to -$0.01 in 2024, then soared by 10300.0% to $1.02 in 2025.
  • Per Business Quant, the three most recent readings for ABBV's EPS (Basic) are $1.02 (Q4 2025), $0.1 (Q3 2025), and $0.53 (Q2 2025).